LakeShore Biopharma Competitors and Similar CompaniesClear all
LakeShore Biopharma's competitors and similar companies include UCB and Ipsen.
 LakeShore Biopharma LakeShore Biopharma (湖岸生物, formerly known as Yisheng Biopharma, YS Biopharma, 辽宁依生生物制药有限公司) is a company engaged in the development, production, marketing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 2002 | Founding Date 1928 | Founding Date 1929 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Beijing, CN HQ Gaithersburg, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more |
Employees | Employees 773 | Employees 9,052 | Employees 5,358 |
Valuation ($) | Valuation ($) 192.1 m | Valuation ($) 34.3 b | Valuation ($) 10.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) ¥615m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) |
Cost of goods | Cost of goods ¥71.1m (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods €659.1m (FY, 2025) |
Gross profit | Gross profit ¥543.8m (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit €3.3b (FY, 2025) |
Net income | Net income (¥100m) (FY, 2025) | Net income €1.6b (FY, 2025) | Net income €445.1m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company